Drug Profile


Alternative Names: Pyladox; RGH 2202

Latest Information Update: 26 Mar 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Gedeon Richter
  • Class Hypothalamic hormones; Nootropics; Small molecules
  • Mechanism of Action Thyrotropin releasing hormone stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cerebral infarction; Cognition disorders; Stroke

Most Recent Events

  • 14 Jun 2000 Discontinued-II for Cerebral infarction in Japan (unspecified route)
  • 14 Jun 2000 Discontinued-III for Cognition disorders in Japan (unspecified route)
  • 09 Mar 1999 A study has been added to the therapeutic trials and adverse events sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top